The Mark Egly Foundation engages partners to speed up the dissemination of information about Mark Egly's medical discoveries. Through our present and future partners, we are reaching out with our data and patent information of our discoveries. Information is being disseminated to patients, medical professionals, and medical teaching facilities as fast as possible. We are doing this to enhance the health of many who have no idea that Alpha1 Antitrypsin could already be affecting their lives and their health future so adversely!
Our current partnerships have begun with individual physicians for many different specialties who have become intrigued that such a major discovery could impact millions in the United States and potentially affect 15% of the population worldwide!